title: Sphingosine kinase is an attractive target for novel pharmacological interventions in non-Hodgkin lymphomas.
authors.affiliation: Department of Human Cancer Genomic Research, KFNCCC&R, Research Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
authors.forename: Shahab
authors.initials: S
authors.lastname: Uddin
authors.forename: Leonidas C
authors.initials: LC
authors.lastname: Platanias
mesh_terms: D016503:Drug Delivery Systems; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000201:enzymology*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors / Q000502:physiology*; D015854:Up-Regulation; D000099157:Sphingosine Kinase
chemical_list: D017853:Phosphotransferases (Alcohol Group Acceptor); D000099157:Sphingosine Kinase